Stock listing

Frankfurt:1YG0 Mendus AB Aktie

German listing (Frankfurt) of Mendus AB · home listing Stockholm:IMMU

Follow Mendus AB into a list and get an email when it puts out news.

Share price · FWB:1YG0

€0.292 EUR -0.011 (-3.6%)

Close on Nov 20, 2026

Past year +9.7% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€0.287 – €0.292 EURNov 20, 2026
Market cap
€18.51M EURAt the close on Nov 20, 2026 · price × 63.48M shares outstanding
52-week range
€0.287 – €0.649 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€32 EURMedian day 0 shares · 54 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Mendus AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:IMMU · Home3.50 SEK-0.10 (-2.8%)23,5163.434.203.3053.60Close on Nov 20, 2026
Frankfurt:1YG0€0.292 EUR-0.011 (-3.6%)—€0.287€0.292€0.287€0.303Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:1YG0 · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.507+0.059+13.2%€0.446€0.509€0.4360
€0.448-0.007-1.5%€0.451€0.452€0.4440
€0.455-0.021-4.4%€0.467€0.473€0.4510
€0.476-0.003-0.6%€0.476€0.476€0.4760
€0.479+0.005+1.1%€0.484€0.484€0.4750
€0.474+0.022+4.9%€0.452€0.474€0.4490
€0.452-0.011-2.4%€0.461€0.461€0.4510
€0.463-0.010-2.1%€0.463€0.463€0.4630
€0.473-0.002-0.4%€0.473€0.473€0.4730
€0.475+0.018+3.9%€0.478€0.478€0.4700
€0.457+0.012+2.7%€0.457€0.457€0.4570
€0.445+0.008+1.8%€0.445€0.445€0.4450
€0.437-0.002-0.5%€0.437€0.437€0.4370
€0.439-0.024-5.2%€0.447€0.448€0.4390
€0.463+0.025+5.7%€0.463€0.463€0.4630
€0.438-0.031-6.6%€0.438€0.438€0.4380
€0.469-0.003-0.6%€0.469€0.469€0.4690
€0.472+0.013+2.8%€0.472€0.472€0.4720
€0.459-0.036-7.3%€0.455€0.461€0.4540
€0.495-0.001-0.2%€0.495€0.495€0.4950
€0.496-0.014-2.7%€0.500€0.503€0.4950
€0.510-0.004-0.8%€0.510€0.510€0.5100
€0.514-0.011-2.1%€0.514€0.514€0.5140
€0.525-0.005-0.9%€0.525€0.525€0.5250
€0.530-0.001-0.2%€0.530€0.530€0.5300
€0.531-0.007-1.3%€0.546€0.547€0.5300
€0.538+0.003+0.6%€0.540€0.540€0.5360
€0.535-0.018-3.3%€0.535€0.535€0.5350
€0.553-0.003-0.5%€0.553€0.553€0.5530
€0.556-0.005-0.9%€0.557€0.557€0.5550
€0.561-0.012-2.1%€0.578€0.579€0.5610
€0.573+0.007+1.2%€0.573€0.573€0.5730
€0.566-0.011-1.9%€0.579€0.583€0.5630
€0.577+0.026+4.7%€0.577€0.577€0.5750
€0.551+0.011+2.0%€0.551€0.551€0.5510
€0.540+0.003+0.6%€0.540€0.540€0.5400
€0.537-0.030-5.3%€0.537€0.537€0.5370
€0.567-0.021-3.6%€0.567€0.567€0.5670
€0.588-0.023-3.8%€0.588€0.588€0.5880
€0.611+0.014+2.3%€0.611€0.611€0.6110
€0.597-0.047-7.3%€0.597€0.597€0.5973,000
€0.644+0.012+1.9%€0.644€0.644€0.6440
€0.6320.0000.0%€0.627€0.639€0.6210
€0.632-0.008-1.3%€0.632€0.632€0.6320
€0.6400.0000.0%€0.640€0.640€0.6400
€0.640-0.001-0.2%€0.640€0.640€0.64022
€0.641+0.022+3.6%€0.641€0.641€0.6410
€0.619+0.006+1.0%€0.619€0.619€0.6190
€0.613+0.005+0.8%€0.613€0.613€0.6130
€0.608-0.011-1.8%€0.608€0.608€0.6080
€0.619+0.020+3.3%€0.619€0.619€0.61922
€0.599-0.023-3.7%€0.599€0.599€0.5990
€0.622+0.013+2.1%€0.622€0.622€0.6220
€0.609+0.013+2.2%€0.609€0.609€0.6090
€0.596+0.012+2.1%€0.596€0.596€0.5960
€0.584-0.003-0.5%€0.584€0.584€0.5840
€0.587-0.007-1.2%€0.587€0.587€0.5870

Splits

1 split · FWB:1YG0 · every price before a split is adjusted for it

DayRatioWhat
1-for-20Consolidation
Ticker
Frankfurt:1YG0
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All Mendus AB news

Mendus AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
17 in the last 12 months · 17 in all · newest Sep 14, 2026 · oldest 2026
Calls
10 calls with a replay · 10 with a transcript · latest Aug 20, 2026
Decks
2 decks · latest Nov 11, 2026

Where Mendus AB is listed

ListingExchangeCountryCurrency
Stockholm:IMMU · Home listingStockholmSwedenSEK
LS Exchange:A40CZ4LS ExchangeGermanyEUR
gettex:1YG0gettexGermanyEUR
Aquis:IMMUSAquisUnited KingdomSEK
Aquis:IMMUSAquisUnited KingdomSEK
Frankfurt:1YG0 · This pageFrankfurtGermanyEUR
Lang & Schwarz:A40CZ4Lang & SchwarzGermanyEUR
Munich:1YG0MunichGermanyEUR
Stuttgart:1YG0StuttgartGermanyEUR

Valuation

Price/book 0.4× against a median of 1.3×: 3rd lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
180.2M SEK
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
0.4×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Mendus AB · OMXSTO:IMMUUS$21.73MUS$17.63Mn/an/an/a0.4×n/a0.0×n/a
BioNxt Solutions Inc · CSE:BNXTUS$22.78MUS$22.72Mn/an/an/an/an/an/a0.22
Polyrizon Ltd. · NASDAQ:PLRZUS$22.61MUS$7.56Mn/an/an/a0.9×n/a0.0×0.67
ME Therapeutics Holdings, Inc. · CSE:METXUS$22.25MUS$21.88Mn/an/an/a49.5×n/a0.0×0.52
CervoMed Inc. · NASDAQ:CRVOUS$22.09MUS$2.49Mn/a285×n/a1.3×n/a0.0×1.97
Sona Nanotech, Inc. · CSE:SONAUS$21.84MUS$22.06Mn/an/an/an/an/an/a0.47
Metagenomi Therapeutics, Inc. · NASDAQ:MGXUS$21.36M−US$44.10Mn/a−6.2×n/a0.2×n/a0.4×1.65
NanoGroup SA · GPW:NNGUS$21.31MUS$18.78Mn/an/an/a4.0×n/a0.0×n/a
Cel-Sci Corporation · AMEX:CVMUS$21.28MUS$14.76Mn/an/an/a1.9×n/a0.0×1.13
ZYUS Life Sciences Corporation · TSXV:ZYUSUS$20.92MUS$25.65Mn/a98.4×n/an/an/an/a-0.02
Xbrane Biopharma AB · OMXSTO:XBRANEUS$20.86MUS$23.45Mn/a1.9×n/a0.4×−49.0%0.1×n/a
Median of the othersUS$21.60MUS$20.33M50.1×1.3×−49.0%0.0×0.60

Forecasts

Analysts' consensus from EODHD, read Nov 13, 2026. Not 6ix's view and not investment advice.

Price target
33.95 SEK · Analysts' mean
EPS, year to Dec 2026
-1.45 · 2 analysts
Revenue, year to Dec 2026
15M · 1 analyst

Team and board

Officers

OfficerRole
Erik MantingChief Executive Officer
Lotta FermChief Financial Officer
Hans PreustingChief Operating Officer
Tariq MughalChief Medical and Scientific Officer

Board

DirectorRole
Sven AndreassonChairman
Dharminder ChahalBoard Member
Helén TuvessonBoard Member
José Manuel OchoaBoard Member
Sijmen de VriesBoard Member

Events

Calls

CallWhenStatus
Mendus (Stockholm:IMMU) Q2 2026 Earnings CallThu, Aug 20, 2026 · 8:00 AM ETReplay
Mendus (Stockholm:IMMU) Q1 2026 Earnings CallFri, May 08, 2026 · 8:00 AM ETReplay
Mendus (Stockholm:IMMU) Q4 2025 Earnings CallWed, Feb 11, 2026 · 8:00 AM ETReplay
Mendus (Stockholm:IMMU) Q3 2025 Earnings CallThu, Nov 13, 2025 · 4:00 AM ETReplay
Mendus (Stockholm:IMMU) Q2 2025 Earnings CallThu, Aug 21, 2025 · 7:00 AM ETReplay
Mendus (Stockholm:IMMU) Q1 2025 Earnings CallTue, May 06, 2025 · 8:00 AM ETReplay
Mendus (Stockholm:IMMU) Q4 2024 Earnings CallThu, Feb 13, 2025 · 2:30 AM ETReplay
Mendus (Stockholm:IMMU) Q3 2024 Earnings CallFri, Nov 08, 2024 · 8:00 AM ETReplay
Mendus (Stockholm:IMMU) Q2 2024 Earnings CallFri, Aug 23, 2024 · 4:00 AM ETReplay
Mendus (Stockholm:IMMU) Q1 2024 Earnings CallFri, May 17, 2024 · 8:00 AM ETReplay

Results days

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 10, 2026 · After close−8.6%
Q2 2026Aug 19, 2026 · After close−0.1%
Q1 2026May 8, 2026+38.3%
Q4 2025Feb 11, 2026 · Before open−3.0%
Q3 2025Nov 13, 2025 · Before open+6.1%
Q2 2025Aug 21, 2025 · Before open−3.4%
Q1 2025May 6, 2025 · Before open−9.7%
Q4 2024Feb 13, 2025 · Before open−1.9%
Q3 2024Nov 8, 2024 · Before open−2.9%
Q2 2024Aug 23, 2024 · Before open−0.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 17, 2024 · Before open−0.5%
Q4 2023Feb 14, 2024 · Before open+1.6%
Q3 2023Nov 9, 2023 · Before open+54.0%
Q2 2023Aug 29, 2023 · Before open−1.3%
Q1 2023May 12, 2023 · Before open−5.3%
Q4 2022Feb 17, 2023 · Before open−6.2%
Q3 2022Nov 11, 2022 · Before open+0.2%
Q2 2022Aug 26, 2022 · Before open−1.1%
Q1 2022May 10, 2022 · Before open−2.7%
Q4 2021Feb 17, 2022 · Before open−1.9%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings29 slidesNov 11, 2026
Q2 2025 Earnings PresentationEarnings28 slidesAug 21, 2025

Open Decks

Financings

RaiseDateIn US dollars
Loan facility with warrants
Announced: SEK 30M · Warrants at SEK 7
Buyers: Fenja Capital II A/S (Lender under the SEK 50 million Loan Facility; drawdown of SEK 30 million Tranche 1 requested; receives 1,935,605 warrants of series 2025/2030)
Jan 30, 2026US$3.38M

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue05.05M28.5M3.38M31.0K016.7M000
Cost of revenue6.29M6.52M6.30M4.85M1.85M1.77M1.64M60.0K71.2K80.8K
Gross profit-6.29M-6.52M28.5M-1.85M-1.84M-1.77M15.0M-60.0K-71.2K-80.8K
Research and development85.1M101.1M92.7M87.0M85.8M47.9M103.1M70.9M57.8M57.8M
Selling, general and administrative35.2M34.1M36.8M48.9M43.5M38.1M28.5M25.6M61.5M10.2M
Operating income-120.3M-135.1M-100.7M-133.7M-130.1M-86.0M-132.3M-97.8M-80.7M-73.5M
Depreciation and amortization6.29M6.50M6.29M4.85M1.85M1.77M1.64M60.0K71.2K80.8K
EBITDA-114.0M-128.6M-94.4M-128.8M-128.2M-84.3M-130.7M-97.8M-80.6M-73.4M
Interest expense3.28M1.22M3.12M5.26M3.31M3.22M17.0K14.0K273.5K0
Income before tax-113.3M-128.4M-101.6M-138.8M-133.4M-89.2M-134.0M-97.9M-80.3M-73.6M
Income tax-565.0K0001.69M-161.1K-635.8K-4
Net income-113.3M-128.4M-101.6M-138.8M-133.4M-89.2M-135.7M-97.9M-80.3M-73.6M
Earnings per share, basic-2.17-2.64-4.39-0.64-0.67-1.08-1.69-1.75-2.85-2.62
Earnings per share, diluted-0.70-0.73-1.17

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents64.7M101.9M120.8M41.9M155.3M167.6M296.8M443.8M128.3M102.9M
Short-term investments-441.0K1.47M09.53M
Receivables2.34M955.0K889.0K3.44M19.7M20.2M18.7M3.31M3.50M2.15M
Inventory-3.30M1.92M10.2M-12.4M1.47M-3.50M
Current assets73.1M134.0M188.4M47.2M185.2M192.6M303.6M450.4M140.8M121.4M
Property, plant and equipment17.0M21.1M23.2M13.9M2.11M1.71M4.33M9.00K69.0K140.4K
Goodwill108.3M108.3M108.3M108.3M108.3M108.3M0
Total assets628.3M696.4M756.0M620.4M721.0M728.7M303.8M450.4M246.1M121.6M
Accounts payable6.66M7.60M8.13M7.41M11.6M10.4M12.8M31.3M11.7M5.04M
Current liabilities27.1M31.3M29.3M59.4M27.6M48.3M30.2M43.5M55.7M18.3M
Long-term debt850.0K850.0K850.0K22.8M36.7M19.0M850.0K850.0K850.0K850.0K
Total debt18.9M22.7M24.5M52.0M36.7M19.0M2.10M850.0K850.0K850.0K
Total liabilities43.3M51.2M51.2M105.9M64.2M67.6M31.0M44.3M56.6M19.2M
Shareholders' equity585.1M645.1M704.7M514.4M656.7M661.1M272.8M406.0M189.6M102.4M
Shares outstanding52.2M48.6M23.1M216.5M199.7M82.7M80.2M55.8M28.2M28.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-81.5M-79.7M-162.8M-109.3M-138.0M-56.6M-145.8M-104.7M-46.4M-33.7M
Capital spending-307.0K-1.83M-1.82M-12.1M-1.36M-464.0K-809.0K-809.0K-809.0K0
Free cash flow-81.8M-81.5M-164.6M-121.4M-139.4M-57.1M-146.6M-104.7M-46.4M-33.7M
Cash from investing-734.0K-1.58M-442.0K-12.3M-1.36M157.3M-251.0K-809.0K10.2M25.7M
Cash from financing45.2M61.5M242.1M8.19M127.0M50.9M756.0K419.6M62.3M16.7M
Share buybacks-1.73M69.1M321.8M0141.2M211.4M67.8M456.3M94.8M16.7M
Change in cash-37.2M-18.9M78.9M-113.5M-12.4M151.6M-147.0M314.9M26.0M70.2M

Open Financials

Cap table

Built by 6ix from Mendus AB’s releases · as of Jan 30, 2026

Common shares
63,483,415
Fully diluted
63,483,415

Fully diluted

LineShares
Common shares63,483,415

Share count over time

CountShares
Nov 22, 202663,483,415

Open Cap table

Shareholders

TradeTradeSharesPriceValueDate
Tariq Mughal
Other member of the company's administrative, management or supervisory body
Buy24,095SEK 5.62SEK 135KNov 16, 2026
Jose Ochoa
Member of the Board of Directors
Buy9,163SEK 6.50SEK 59,560Nov 4, 2026
Sven Arne Andreasson
Chairman of the Board of Directors
Buy20,641SEK 6.50SEK 134KJul 24, 2026
Johannes Preusting
Member of the Board of Directors
Buy9,185SEK 6.50SEK 59,703Jul 24, 2026
Dharminder Chahal
Member of the Board of Directors
Buy10,673SEK 6.50SEK 69,375Jul 23, 2026
Sijmen de Vries
Member of the Board of Directors
Buy9,300SEK 6.50SEK 60,450Jul 23, 2026
Erik Manting
Chief Executive Officer (CEO)/Managing Directory
Buy174,804SEK 5.62SEK 982KJun 12, 2026
Ann-Charlotte Ferm
Chief Financial Officer (CFO)
Buy60,228SEK 5.62SEK 338KJun 12, 2026
Ann-Charlotte Ferm
Chief Financial Officer (CFO)
Buy2,500SEK 5.10SEK 12,750Jun 12, 2026
Ann-Charlotte Ferm
Chief Financial Officer (CFO)
Buy2,272SEK 5.10SEK 11,587Jun 11, 2026
All 22 trades
TradeTradeSharesPriceValueDate
Sijmen de Vries
Member of the Board of Directors
Buy72,388SEK 5.15SEK 373KMay 8, 2026
Helen Tuvesson Andersson
Member of the Board of Directors
Buy15,654SEK 4.25SEK 66,564Apr 10, 2026
Dharminder Chahal
Member of the Board of Directors
Buy16,315SEK 4.25SEK 69,375Apr 10, 2026
Johannes Preusting
Member of the Board of Directors
Buy22,488SEK 4.25SEK 95,623Apr 9, 2026
Sven Arne Andreasson
Chairman of the Board of Directors
Buy32,189SEK 4.25SEK 137KApr 8, 2026
Helen Tuvesson Andersson
Member of the Board of Directors
Buy12,993SEK 5.12SEK 66,563Dec 30, 2025
Dharminder Chahal
Member of the Board of Directors
Buy13,542SEK 5.12SEK 69,376Dec 29, 2025
Sven Arne Andreasson
Chairman of the Board of Directors
Buy26,718SEK 5.12SEK 137KDec 29, 2025
Johannes Preusting
Member of the Board of Directors
Buy12,078SEK 5.12SEK 61,876Dec 29, 2025
Sven Arne Andreasson
Chairman of the Board of Directors
Buy55,000SEK 5.00SEK 275KDec 17, 2025
Dharminder Chahal
Member of the Board of Directors
Buy55,000SEK 5.00SEK 275KDec 16, 2025
Erik Manting
Chief Executive Officer (CEO)/Managing Directory
Buy200,000SEK 5.00SEK 1MDec 16, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dharminder ChahalBoard Member · Since at least Apr 2, 2026
Erik MantingChief Executive Officer · Since at least Sep 14, 2026
Hans PreustingChief Operating Officer · Since at least Apr 2, 2026
Helén TuvessonBoard Member · Since at least Apr 2, 2026
José Manuel OchoaBoard Member · Since at least Apr 2, 2026
Lotta FermChief Financial Officer · Since at least Nov 4, 2026
Sijmen de VriesBoard Member · Since at least Apr 2, 2026
Sven AndreassonChairman · Since at least Apr 2, 2026
Tariq MughalChief Medical and Scientific Officer · Since at least Apr 17, 2026

Open People

Log in to ask 6ix AI your own questions about Mendus AB.